A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy

Journal of Controlled Release

Volumn 127, Issue 2, 2008, Pages 173-179

  Duan, Yajun ^a   Zheng, Junnian ^b   Han, Sufang ^a   Wu, Yi ^b   Wang, Yanming ^a   Li, Deguan ^c   Kong, Deling ^a   Yu, Yaoting ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

G250 antibody; Gene therapy; PEI; Renal cell carcinoma; Targeted gene delivery

Indexed keywords

BIOASSAY; CELLS; DNA; GENES; MUSCLE; TUMORS;

GENE THERAPY; POLYETHYLENIMINE (PEI); RENAL CELL CARCINOMA (RCC); TARGETED GENE DELIVERY;

MONOCLONAL ANTIBODIES;

IMMUNOGLOBULIN G; LUCIFERASE; MONOCLONAL ANTIBODY G250; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LIGHT SCATTERING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DNA; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; IMMUNOGLOBULIN G; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; MYOCYTES, SMOOTH MUSCLE; NIH 3T3 CELLS; PLASMIDS; POLYETHYLENEIMINE; RABBITS;

EID: 41249102387     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.01.016     Document Type: Article

References (33)

1. Chiu S.-J., Ueno N.T., and Lee R.J. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release 97 (2004) 357-369
2. Lungwitz U., Breunig M., Blunk T., and Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60 (2005) 247-266
3. van Zanten J., Doornbos-van der Meer B., Audouy S., Kok R.J., and de Leij L. A nonviral carrier for targeted gene delivery to tumor cells. Cancer Gene Ther. 11 (2004) 156-164
4. Moffatt S., Papasakelariou C., Wiehle S., and Cristiano R. Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate. Gene Ther. 13 (2006) 761-772
5. Demeneix B., and Behr J.P. Polyethylenimine (PEI). Adv. Genet. 53 (2005) 217-230
6. Kim E.M., Jeong H.J., Park I.K., Cho C.S., Moon H.B., Yu D.Y., Bom H.S., Sohn M.H., and Oh I.J. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies. J. Control. Release 108 (2005) 557-567
7. Densmore C.L., Orson F.M., Xu B., Kinsey B.M., Waldrep J.C., Hua P., Bhogal B., and Knight V. Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Molec. Ther. 1 2 (Feb 2000) 180-188
8. Merdan T., Callahan J., Petersen H., Kunath K., Bakowsky U., Kopeckova P., Kissel T., and Kopecek J. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug. Chem. 14 (2003) 989-996
9. Leamon C.P., Weigl D., and Hendren R.W. Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10 (1999) 947-957
10. Erbacher P., Remy J.S., and Behr J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6 (1999) 138-145
11. Suk J.S., Suh J., Choy K., Lai S.K., Fu J., and Hanesa J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 27 (2006) 5143-5150
12. Fishbein I., Stachelek S.J., Connolly J.M., Wilensky R.L., Alferiev I., and Levy R.J. Site specific gene delivery in the cardiovascular system. J. Control. Release 109 (2005) 37-48
13. Bleumer I., Knuth A., Oosterwijk E., Hofmann R., Varga Z., Lamers C., Kruit W., Melchior S., Mala C., Ullrich S., De Mulder P., Mulders P.F.A., and Beck J. A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br. J. Cancer 90 (2004) 985-990
14. Grabmaier K., De Weijert M., Uemura H., Schalken J., and Oosterwijk E. Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies. Urology 60 2 (2002) 357-362
15. Uemura H., Nakagawa Y., Yoshida K., Saga S., Yoshikawa K., Hirao Y., and Oosterwijk E. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br. J. Cancer 81 4 (1999) 741-746
16. Jongmans W., van den Oudenalder K., Tiemessen D.M., Molkenboer J., Willemsen R., Mulders P.F., and Oosterwijk E. Targeting of adenovirus to human renal cell carcinoma cells. Urology 62 3 (Sep 2003) 559-565
17. Duerrbach A., Angevin E., Poncet P., Rouleau M., Chavanel G., Chapel A., Thierry D., Gorter A., Hirsch R., Charpentier B., Senik A., and Hirsch F. Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro. Cancer Gene Ther. 6 6 (1999) 564-571
18. Chang A.Y., and Keng P.C. Inhibition of cell growth in synchronous human hypernephroma cells by recombinant interferon alpha-D and irradiation. J. Interf. Res. 3 4 (1983) 379-385
19. Xiong J., Yao Y.-C., Zi X.-Y., Li J.-X., Wang X.-M., Ye X.-T., Zhao S.-M., Yan Y.-B., Yu H.-Y., and Hu Y.-P. Expression of hepatitis B virus X protein in transgenic mice. World J. Gastroenterol. 9 1 (2003) 112-116
20. Okahara F., Itoh K., Nakagawara A., Murakami M., Kanaho Y., and Maehama T. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. Mol. Biol. Cell 17 11 (Nov 2006) 4888-4895
21. Ouchi T., Yamabe E., Hara K., Hirai M., and Ohya Y. Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide. J. Control. Release 94 2-3 (Feb 10 2004) 281-291
22. Deng Y.M., Wu B.J., Witting P.K., and Stocker R. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110 13 (Sep 28 2004) 1855-1860
23. Simpson J.S., Hughes J.P., and Friesen H.G. A monoclonal antibody to the growth hormone receptor of rabbit liver membranes. Endocrinology 112 6 (Jun 1983) 2137-2141
24. Thorpe P.E., Blakey D.C., Brown A.N., Knowles P.P., Knyba R.E., Wallace P.M., Watson G.J., and Wawrzynczak E.J. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: anti-tumor effects, in vivo fate, and tumor cell mutants. J. Natl. Cancer Inst. 79 5 (1987) 1101-1112
25. Medina L.O., Veloso C.A., de Abreu Borges E., Isoni C.A., Calsolari M.R., Chaves M.M., and Nogueira-Machado J.A. Determination of the antioxidant status of plasma from type 2 diabetic patients. Diabetes Res. Clin. Pract. 77 2 (Aug 2007) 193-197
26. Gupta M., and Gupta A.K. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J. Control. Release 99 (2004) 157-166
27. Tan M., Lan K.-H., Yao J., Lu C.-H., Sun M., Neal C.L., Lu J., and Yu D. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a Novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. Cancer Res. 66 7 (2006) 3764-3772
28. Chapel A., Deas O., Bensidhoum M., François S., Mouiseddine M., Poncet P., Dürrbach A., Aigueperse J., Gourmelon P., Gorin N.C., Hirsch F., and Thierry D. In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery. Genet. Vaccines Ther. 2 1 (2004) 16
29. Oosterwijk E., Ruiter D.J., Hoedemaeker P.J., Pauwels E.K., Jonas U., Zwartendijk J., and Warnaar S.O. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer 38 (1986) 489-494
30. Suzuki M., Takayanagi A., and Shimizu N. Recombinant single-chain antibodies with various oligopeptide tails for targeted gene delivery. Gene Ther. 10 9 (2003) 781-788
31. Kircheis R., Wightman L., and Wagner E. Design and gene delivery activity of modified spolyethylenimines. Adv. Drug Deliv. Rev. 53 3 (2001) 341-358
32. Li S., Tan Y., Viroonchatapan E., Pitt B.R., and Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. 278 (2000) L504-L511
33. Kunath K., Merdan T., Hegener O., Haberlein H., and Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J. Gene Med. 5 (2003) 588-599